AsymBio’s Conjugation Toolbox supports customized process development across both random and site-specific conjugation technologies. For IND-enabling programs, conjugation process development ...
The antibody-drug conjugate landscape is facing a critical inflection point. As it stands, manufacturing complexity could pose a threat to future innovation, despite the unmatched market demand. With ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results